Primary information |
---|
sequence ID | Seq_3003 |
Peptide sequence | GPPGPPGPPGPPGPPS |
CancerPDF_ID | CancerPDF_ID10789, CancerPDF_ID10791, |
PMID | 21805675,21805675 |
Protein Name | Collagen alpha-1(I) chain,Collagen alpha-1(I) chain |
UniprotKB Entry Name | CO1A1_HUMAN,CO1A1_HUMAN |
Fluid | Urine,Urine |
M/Z | 1409.6706,1425.6628 |
Charge | NA,NA |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | MALDI-TOF,MALDI-TOF |
Peptide Identification technique | MALDI-TOF-MS,MALDI-TOF-MS |
Quantification Technique | NA,NA |
Labelled/Label Free | Label Free,Label Free |
FDR | 1,1 |
CancerPDF_ID | CancerPDF_ID10789, CancerPDF_ID10791, |
p-Value | NA,NA |
Software | NA,NA |
Length | 16,16 |
Cancer Type | Muscle-invasive bladder cancer,Muscle-invasive bladder cancer |
Database | SwissProt Database,SwissProt Database |
Modification | "Oxidation: 3, 5, 6","Oxidation: 5, 6, 8, 9" |
Number of Patients | 751 bladder cancer and 127 control,751 bladder cancer and 127 control |
Regulation | Differentially expressed between cancer vs normal samples,Differentially expressed between cancer vs normal samples |
Validation | Mann-Whitney tests and areas under receiver-operator characteristic,Mann-Whitney tests and areas under receiver-operator characteristic |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | |
Primary information |
---|
sequence ID | Seq_3018 |
Peptide sequence | GPPGpPGPpGPPGPPS |
CancerPDF_ID | CancerPDF_ID3440, |
PMID | 27026199 |
Protein Name | Collagen alpha-1(I) chain |
UniprotKB Entry Name | CO1A1_HUMAN |
Fluid | Urine |
fdr | 1392.67 |
Profiling Technique | "CE-MS, Micro-TOF-MS" |
Peptide Identification technique | MS-MS |
Labelled/Label Free | Label Free |
CancerPDF_ID | CancerPDF_ID3440, |
p-Value | less than 0.05 |
Software | Proteome Discoverer 1.2 |
Length | 16 |
Cancer Type | Bladder cancer |
Database | Uniprot Human non-redundant Database |
Modification | p:Hydroxy-Proline |
Number of Patients | 451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls); |
Regulation | Differentially expressed between primary UBC and normal individual |
Validation | Independent Validation |
Sensitivity | For testing dataset 91% |
Specificity | For testing dataset 68% |
Accuracy | For testing dataset 76% |
Peptide Atlas | NA |
IEDB | NA |